216 related articles for article (PubMed ID: 24996257)
1. Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters.
Yoon YK; Ali MA; Wei AC; Choon TS; Ismail R
Eur J Med Chem; 2015 Mar; 93():614-24. PubMed ID: 24996257
[TBL] [Abstract][Full Text] [Related]
2. Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives.
Keng Yoon Y; Ashraf Ali M; Choon TS; Ismail R; Chee Wei A; Suresh Kumar R; Osman H; Beevi F
Biomed Res Int; 2013; 2013():926309. PubMed ID: 24381946
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
[TBL] [Abstract][Full Text] [Related]
5. SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
Jadhav GR; Shaikh MU; Kale RP; Shiradkar MR; Gill CH
Eur J Med Chem; 2009 Jul; 44(7):2930-5. PubMed ID: 19150154
[TBL] [Abstract][Full Text] [Related]
6. Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship.
Gobis K; Foks H; Suchan K; Augustynowicz-Kopeć E; Napiórkowska A; Bojanowski K
Bioorg Med Chem; 2015 May; 23(9):2112-20. PubMed ID: 25797161
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial activity of some new 3-heterocyclic substituted chromones.
Gasparová R; Lácová M; el-Shaaer HM; Odlerová Z
Farmaco; 1997 Apr; 52(4):251-3. PubMed ID: 9241831
[TBL] [Abstract][Full Text] [Related]
8. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
Gill C; Jadhav G; Shaikh M; Kale R; Ghawalkar A; Nagargoje D; Shiradkar M
Bioorg Med Chem Lett; 2008 Dec; 18(23):6244-7. PubMed ID: 18930654
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel N' (4-aryloxybenzylidene)- 1H-benzimidazole-2 carbohydrazide derivatives as anti-tubercular agents.
Siddiki AA; Bairwa VK; Telvekar VN
Comb Chem High Throughput Screen; 2014; 17(7):630-8. PubMed ID: 24625232
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH
Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
Shingalapur RV; Hosamani KM; Keri RS
Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.
Gobis K; Foks H; Bojanowski K; Augustynowicz-Kopeć E; Napiórkowska A
Bioorg Med Chem; 2012 Jan; 20(1):137-44. PubMed ID: 22153872
[TBL] [Abstract][Full Text] [Related]
14. QSAR analysis of a set of benzimidazole derivatives based on their tuberculostatic activities.
Geban O; Ertepinar H; Ozden S
Pharmazie; 1996 Jan; 51(1):34-6. PubMed ID: 8999432
[TBL] [Abstract][Full Text] [Related]
15. Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
Devi Bala B; Muthusaravanan S; Choon TS; Ashraf Ali M; Perumal S
Eur J Med Chem; 2014 Oct; 85():737-46. PubMed ID: 25129868
[TBL] [Abstract][Full Text] [Related]
16. Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity.
Chandrasekera NS; Alling T; Bailey MA; Files M; Early JV; Ollinger J; Ovechkina Y; Masquelin T; Desai PV; Cramer JW; Hipskind PA; Odingo JO; Parish T
J Med Chem; 2015 Sep; 58(18):7273-85. PubMed ID: 26295286
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives.
Kalalbandi VK; Seetharamappa J; Katrahalli U; Bhat KG
Eur J Med Chem; 2014 May; 79():194-202. PubMed ID: 24735645
[TBL] [Abstract][Full Text] [Related]
18. Aminopyrazinoic acid esters as potential antimycobacterial drugs.
Doležal M; Vobicková J; Servusová B; Paterová P
Ceska Slov Farm; 2013 Apr; 62(2):84-8. PubMed ID: 23822573
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents.
Raghu MS; Pradeep Kumar CB; Yogesh Kumar K; Prashanth MK; Alshahrani MY; Ahmad I; Jain R
Bioorg Med Chem Lett; 2022 Mar; 60():128604. PubMed ID: 35123004
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]